Although the benefit/risk of therapeutic inhibition of VSMC proliferation ... is to inhibit cellular proliferation by targeting cell cycle regulation. Here we will review the current understanding ...

Paolo Tarantino, MD, PhD, medical oncologist and clinical fellow at Dana-Farber Cancer Institute, discusses elacestrant (Orserdu) as a well-tolerated treatment option for patients with hormone ...

2014;63(RR-03):1-10. Centers for Disease Control and Prevention. HIV pre-exposure prophylaxis (PrEP) care system. Li CX, Li YY, He LP, et al. The predictive role of CD4+ cell count and CD4/CD8 ratio ...